Author

Martin Laque

Observed names: M Laque, M. Laque

Observed institutions: Centers for Disease Control and Prevention, Emory University, University of the Witwatersrand, Chris Hani Baragwanath Hospital, Lancet Laboratories, Evelina London Children's Healthcare, Respiratory and Meningeal Pathogens Research Unit, National Research Foundation

OpenAlex ID: A5048827447

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

2019 · Mark D Lyttle, Naomi E A Rainford, et al. · The Lancet · 252

Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial

2009 · Clare L Cutland, Shabir A Madhi, et al. · The Lancet · 99

Chlorhexidine Maternal-Vaginal and Neonate Body Wipes in Sepsis and Vertical Transmission of Pathogenic Bacteria in South Africa: A Randomized, Controlled Trial

2010 · Clare L. Cutland, Shabir A. Madhi, et al. · Obstetrical & Gynecological Survey · 12

G348(P) Use of the ‘step-by-step’ approach in identifying low risk febrile infants in the emergency department

2018 · L Wells, C Stark, et al.

Surveillance of Causes of Sepsis in Young African Infants

2008 · C. Cutland, M. Kuwanda, et al. · International Journal of Infectious Diseases

Works count: 5

Citation count: 363

H-index: 3

I10-index: 3